Fulminant Cryoglobulinemic Glomerulonephritis Seven Years After Viral Eradication: A Case Report (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0727; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "The patient received steroids, rituximab was not started becasue of case deterioration, required hemodialysis but eventually developed hypoxic respiratory failure and died within 3 weeks of presentation Discussion This case illustrates that type II CryoGN can emerge despite long-standing HCV eradication when triggered by an intense pro-inflammatory state. We posit that recent surgical trauma and MRSA infection acted as a catalyst, driving a pre-existing, low-level IgM kappa paraprotein to form pathologic cryoglobulins independent of active HCV replication. Cryoglobulinemia should remain in the differential for patients with a history of HCV (regardless of SVR status) presenting with new-onset rash and proteinuria/hematuria, following inflammatory triggers"
Case report • Clinical • Acute Kidney Injury • Complement-mediated Rare Disorders • Fibrosis • Glomerulonephritis • Hepatitis C • Hepatology • Immunology • Infectious Disease • Inflammation • Lupus Nephritis • Monoclonal Gammopathy • Nephrology • Renal Disease • Respiratory Diseases
|
|
Anees Mohammed Mubarak; Saber Khalid; Hussin Sameh Almabry; Juan Carlos Q. Velez; Muner Mohamed
|